Search Results

You are looking at 91 - 100 of 153 items for :

  • "renal cell carcinoma" x
Clear All
Full access

Meic H. Schmidt, Paul Klimo Jr and Frank D. Vrionis

compression from metastatic malignancy . Clin Orthop 1988 ; 233 : 177 – 197 . 58 Jackson RJ Loh SC Gokaslan ZL . Metastatic renal cell carcinoma of the spine: surgical treatment and results . J Neurosurg 2001 ; 94 : 18 – 24 . 59

Full access

Amanda Bennett, Ronald M. Bukowski, Keith Flaherty, J. Cameron Muir, Craig D. Turner and Sam Donaldson

18th Annual Conference and was joined in a panel discussion by several of her late husband’s physicians. Mr. Foley’s tumor, variously diagnosed as collecting duct carcinoma and papillary renal cell carcinoma, was an incidental finding in 2000

Full access

Barbara Burtness

more common in those with renal cell carcinoma than in those with colorectal cancer,” she remarked. Finally, patients who are treated with lenalidomide or the immune checkpoint inhibitor ipilimumab may be at risk of developing a skin rash. 7 , 8

Full access

Vivek Subbiah and Kanishka Sircar

immunotherapy: mismatch meets its match . Oncologist 2019 ; 24 : 1 – 3 . 10.1634/theoncologist.2017-0519 30352943 11. Singh RR , Murugan P , Patel LR , Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma

Full access

Thomas Kaley and Louis B. Nabors

), melanoma, or renal cell carcinoma. A separate study of 110 patients who received SRS only or SRS plus an immune checkpoint inhibitor showed that fewer brain metastases developed with concurrent SRS and immune checkpoint inhibitor. 8 A single

Full access

Fiona Tsui-Fen Cheng, Fu Ou-Yang, Nina Lapke, Kai-Che Tung, Yen-Kung Chen, Yuh-Yu Chou and Shu-Jen Chen

(TKI) pazopanib, which is indicated for the treatment of renal cell carcinoma and soft tissue sarcoma. This case report shows that pazopanib induced an encouraging clinical response in a patient with breast cancer and FGFR1 amplification. Importantly

Full access

Mary B. Daly, Robert Pilarski, Jennifer E. Axilbund, Saundra S. Buys, Beth Crawford, Susan Friedman, Judy E. Garber, Carolyn Horton, Virginia Kaklamani, Catherine Klein, Wendy Kohlmann, Allison Kurian, Jennifer Litton, Lisa Madlensky, P. Kelly Marcom, Sofia D. Merajver, Kenneth Offit, Tuya Pal, Boris Pasche, Gwen Reiser, Kristen Mahoney Shannon, Elizabeth Swisher, Nicoleta C. Voian, Jeffrey N. Weitzel, Alison Whelan, Georgia L. Wiesner, Mary A. Dwyer and Rashmi Kumar

cancer, esophageal glycogenic acanthosis (≥3), lipomas, mental retardation, papillary or follicular variant of papillary thyroid cancer, thyroid structural lesions (eg, adenoma, nodules, goiter), renal cell carcinoma, a single gastrointestinal hamartoma

Full access

Laura C. Kennedy, Shailender Bhatia, John A. Thompson and Petros Grivas

everolimus in advanced renal-cell carcinoma . N Engl J Med 2015 ; 373 : 1803 – 1813 . 26406148 10.1056/NEJMoa1510665 36. Powles T , Durán I , van der Heijden MS , . Atezolizumab versus chemotherapy in patients with platinum-treated locally

Full access

Bin Wu and Lizheng Shi

everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the US . J Med Econ 2015 ; 18 : 200 – 209 . 18. Hansen RN , Hackshaw MD , Nagar SP , . Health care costs among renal cancer patients using

Full access

Alan P. Venook, Maria E. Arcila, Al B. Benson III, Donald A. Berry, David Ross Camidge, Robert W. Carlson, Toni K. Choueiri, Valerie Guild, Gregory P. Kalemkerian, Razelle Kurzrock, Christine M. Lovly, Amy E. McKee, Robert J. Morgan, Anthony J. Olszanski, Mary W. Redman, Vered Stearns, Joan McClure and Marian L. Birkeland

hurdles regarding toxicity and the need for greater interindustry cooperation. Renal Cell Carcinoma Renal cell carcinoma (RCC) is diagnosed in approximately 65,000 patients annually, and leads to approximately 13,000 deaths per year, representing